Dashboard
Portfolios
Watchlist
Community
Discover
Screener
53
537578
Community Contributor
Member since 2025
Views
650
Total number of views
Fair Values Set
7
Total number of fair values set
Comments
6
Total number of comments
Followers
0
Total number of followers
No bio added yet
No link added
Narratives
Watchlists
Portfolios
Discussions
Likes
RXRX
·
2 months ago
RXRX: FAP Trial Success Will Support Future Margin Expansion Potential
I now believe Recursion Pharmaceuticals will one day be the Palantir of biotechnology! Najat Khan the new CEO will lead RXRX to greatness!
0
|
0
RXRX
·
3 months ago
RXRX: Positive FAP Trial Results Will Support Future Margin Expansion
RXRX will be a winner with Najat Khan! With her leadership recursion pharmaceuticals will one day be the next Palantir in biotechnology!!!
0
|
0
RXRX
·
3 months ago
RXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum
Regarding FAP JP Morgan said there’s a 60% chance REC-4881 will be approved and will generate $1,000,000,000! They also say 50,000 people in the world have FAP!
0
|
0
RXRX
·
3 months ago
RXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum
The FDA will approve REC-4881 within 18 months! When this happens everything falls into place!
0
|
0
RXRX
·
4 months ago
RXRX: Positive TUPELO Data Will Drive Future AI-Enabled Margin Expansion
Thank God the old CEO is stepping down! Continues to unload massive amounts of shares!
0
|
1
RXRX
·
5 months ago
RXRX: New CEO Appointment Will Spark Stronger Margins And AI-Driven Momentum
Najat Khan will lead RXRX to greatness! With her experience and expertise in biotechnology RXRX will have a banner year in 2026!
0
|
0